Biomarkers of apalutamide response identified in nonmetastatic CRPC
medwireNews: Further analysis of patients with nonmetastatic castration-resistant prostate cancer (CRPC) from the SPARTAN trial has identified molecular biomarkers associated with... Read More
Study highlights PSA screening gaps for transgender people
medwireNews: US researchers report a lower uptake of prostate-specific antigen (PSA) screening by transgender individuals than cisgender straight men. However,... Read More
HSD3B1 Variant May Predict Treatment Response in Advanced Prostate Cancer
The HSD3B1 1245C variant allele could be used as a biomarker to predict treatment response in different groups of men... Read More